Viking Therapeutics, Inc. (VKTX)
32.33
-1.59
(-4.69%)
USD |
NASDAQ |
Mar 20, 16:00
32.52
+0.19
(+0.59%)
After-Hours: 20:00
Viking Therapeutics Research and Development Expense (Quarterly) : 153.46M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Amgen, Inc. | 2.151B |
| Pfizer Inc. | 3.133B |
| Hims & Hers Health, Inc. | 40.96M |
| Altimmune, Inc. | 18.38M |